Product Information
GEMMILY 1 MG-20 MCG CAPSULE is a generic product labeled by Xiromed LLC, priced at $0.9618 per EA under NDC 70700015285. Its NADAC has been published 294 times since Feb 17, 2021.
FDA first approved this application on Nov 9, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
GEMMILY 1 MG-20 MCG CAPSULE
norethindrone acetate and ethinyl estradiol, and ferrous fumarateManufacturer
Xiromed LLCNDC
70700015285
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA213317FDA Approved
11/9/2020
TE Code
AB
On Market Since
11/9/2020
Price Statistics
The NADAC for GEMMILY 1 MG-20 MCG CAPSULE has been published 294 times since Feb 17, 2021, and over the history we have for it it has declined 79.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9618 per EA |
|---|---|
| All-time high | $4.6596 (Mar 10, 2021) |
| All-time low | $0.6326 (May 20, 2026) |
| 52-week high | $1.0037 |
| 52-week low | $0.6326 |
| Median price | $1.0771 |
| Average price | $1.5101 |
| Largest weekly change | +64.6% (Jan 18, 2023) |
| Weeks tracked | 294 |
| Tracking since | Feb 17, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xiromed LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
norethindrone acetate and ethinyl estradiol, and ferrous fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GEMMILY 1 MG-20 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GEMMILY 1 MG-20 MCG CAPSULE, manufactured by Xiromed LLC, is $0.9618 per EA (NDC 70700015285), effective Sep 30, 2026.
How has the price of GEMMILY 1 MG-20 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for GEMMILY 1 MG-20 MCG CAPSULE has declined 79.4%. It has been tracked across 294 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for GEMMILY 1 MG-20 MCG CAPSULE?
Since Feb 17, 2021, the NADAC for GEMMILY 1 MG-20 MCG CAPSULE has ranged from a low of $0.6326 (May 20, 2026) to a high of $4.6596 (Mar 10, 2021), with a median of $1.0771 per EA.
Are there cheaper alternatives to GEMMILY 1 MG-20 MCG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HAILEY 24 FE 1 MG-20 MCG TAB, is $0.1748 per EA — about 82% below GEMMILY 1 MG-20 MCG CAPSULE.
Who manufactures GEMMILY 1 MG-20 MCG CAPSULE?
GEMMILY 1 MG-20 MCG CAPSULE (NDC 70700015285) is labeled by Xiromed LLC, and CMS classifies it as a generic product.